Published online before print January 13, 2003, doi: 10.1161/01.HYP.0000050961.70182.56
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:335.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
Nephron Number, Renal Function, and Arterial Pressure in Aged GDNF Heterozygous Mice
From the Department of Anatomy and Cell Biology (L.A.C.-M., J.F.B.) and the Department of Physiology (M.M.K., W.P.A.), Monash University, Victoria, Australia; and the Department of Anatomical Pathology, Alfred Hospital (J.D.), Melbourne, Australia.
Correspondence to John F. Bertram, PhD, Department of Anatomy and Cell Biology, PO Box 13C, Monash University, VIC, 3800, Australia. E-mail john.bertram{at}med.monash.edu.au
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
The loss of one allele for glial cell line–derived neurotrophic factor (GDNF) results in
30% fewer but normal sized glomeruli in young mice. Low nephron number, inherited or acquired, has been linked to increased risk of development of hypertension and renal failure. This study examines whether GDNF heterozygous mice, with an inherent reduction in nephron number, demonstrate a deterioration in renal structure and function and rise in arterial pressure in later life. Fourteen-month-old male GDNF heterozygous (n=7) and wild-type (n=6) mice were anesthetized and prepared for measurement of mean arterial pressure, glomerular filtration rate (GFR), and renal blood flow. After measurement of renal function, kidneys were fixed for stereological determination of total glomerular number and mean glomerular volume. Mean arterial pressure was, on average, 18 mm Hg higher in GDNF heterozygous (98±4 mm Hg) than wild-type mice (80±2 mm Hg; P<0.01). However, GFR (0.656±0.054 versus 0.688±0.076 mL/min per g kidney wt) and renal blood flow (5.29±0.42 versus 4.70±0.34 mL/min per g kidney wt) were not different between groups. Fourteen-month-old GDNF heterozygous mice had 30% fewer glomeruli than wild-type mice (9206±934 versus 13440±1275; P<0.01) and significantly larger glomeruli (4.51±0.39 versus 3.72±0.63x10-4mm3; P<0.01). Thus, aged GDNF heterozygous mice maintained a normal GFR and renal blood flow despite reduced nephron numbers. The elevated arterial pressure, glomerular hypertrophy, and hyperfiltration demonstrated in the GDNF heterozygous mice at this age may indicate a compensatory mechanism whereby GFR is maintained in the presence of a reduced nephron endowment.
Key Words: mice • hypertension, genetic • kidney • blood flow • arterial pressure
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
It has been hypothesized that low nephron numbers in the kidney may increase the risk of development of cardiovascular diseases such as hypertension and chronic renal failure and reduce the long-term success of renal allografts.1–4 Thus, factors that affect nephrogenesis in the fetus may not only be critical in kidney development but also affect subsequent adult kidney function and underlie much subsequent renal pathology and abnormal physiology.
Glial cell line-derived neurotrophic factor (GDNF)5–7 has been shown to play a key role in kidney development through actions at the RET and GFR
1 receptor and coreceptor.8,9 Specifically, GDNF has been demonstrated to initiate budding of the ureteric duct from the Wolffian duct, branching of the ureteric epithelium within the metanephric mesenchyme, and the formation of new nephrons at the branch tips.5–7 Increasing the levels of exogenous GDNF in metanephric culture medium leads to increases in both the number of ureteric branches and number of developing nephrons.7 In the late 1990s, knockout studies demonstrated that homozygous null mutants for GDNF,10–13 as well as RET14 and GFR1,15,16 showed bilateral renal agenesis and died shortly after birth. In contrast, GDNF, RET, and GFR1 heterozygous mice were both fertile and viable. Whereas the RET and GFR1 heterozygotes demonstrated a normal renal phenotype, the GDNF heterozygotes showed an array of renal phenotypes, ranging from two smaller kidneys, many with abnormal shapes and cortical cysts, to unilateral renal agenesis.10–13
These results indicated that GDNF gene dosage influenced kidney development, with the loss of one allele being sufficient to cause a significant renal phenotype. Recently we found that the kidneys of these GDNF heterozygous mice at 30 days of age were 25% smaller than their wild-type littermates despite similar body weights.17 Furthermore, stereologic estimates of nephron number identified a 30% decrease in nephron endowment in young heterozygous GDNF mice compared with wild-type mice. The GDNF heterozygous mouse thus provides a genetic model with which to test the hypothesis that an inherent reduction in nephron number contributes to the development of cardiovascular and renal disease that is uncomplicated by changes in birth and body weight. In the majority of cases in humans, cardiovascular and renal disease does not become apparent until later in life. Thus this study examines whether GDNF heterozygous mice with a 30% reduction in nephron endowment go on to demonstrate a deterioration in renal function, glomerular hypertrophy, and/or increases in arterial pressure later in life.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
All experiments were approved in advance by Monash University Departments of Physiology and Anatomy and Cell Biology Animal Ethics Committees and were conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.
Our GDNF mouse colony was initially established with founders from the laboratory of Dr Heiner Westphal (Laboratory of Mammalian Genes and Development, National Institutes of Health, Bethesda, Md).10,11 Male GDNF heterozygous mice (129Sv-C57BL/6 hybrid; 6th generation C57BL/6 back-cross) were mated with female C57BL/6 mice. After weaning, tail tissue was obtained from all mice for genotyping by polymerase chain reaction,10,11,17 and the mice were coded such that the following experiments were carried out in a blinded fashion.
Blood Pressure and Renal Function
At 14 months of age, male GDNF wild-type (14.0±0.3 months; n=7) and heterozygous (14.1±0.2 months; n=6) mice were anesthetized (Inactin, 100 mg/kg IP; Sigma Chemical Co; and ketamine, 10 mg/kg IP; Parnell Laboratories) and placed on a heating table to maintain body temperature at 37°C. The trachea was catheterized (PE-90), and a stream of O2 was blown onto the end of the tube to maintain a stable arterial pressure throughout the experiment. The left femoral artery was catheterized (pulled SV-50) for measurement of blood pressure and heart rate and to obtain a terminal arterial blood sample, and the left femoral vein (pulled SV-50) was catheterized for infusion of maintenance fluids (6% BSA, 2.5 µL/min during surgery). After surgery, the infusion was changed to a 1% BSA solution containing 3H-inulin (5.58 µCi/mL) and 14C-PAH (1.7 µCi/mL) for estimation of glomerular filtration rate (GFR) and effective renal plasma flow by renal clearance methods, and the mice were allowed 1 hour to equilibrate. The equilibration period was followed by two 20-minute urine collection periods, after which an arterial blood sample (100 µL) was taken. Urinary protein concentrations were measured by means of the Bradford method.18 Sodium and potassium concentrations were analyzed with a Technicon autoanalyzer flame photometer IV.
At the completion of the experiment, kidneys were rapidly excised, weighed, and immersion-fixed in 2% paraformaldehyde and 2% glutaraldehyde in 0.1 mol/L phosphate buffer. The left kidneys were then processed for embedding in glycolmethacrylate for stereologic estimation of total nephron number and mean glomerular volume. Right kidneys were processed and embedded in paraffin, and sections were stained with hematoxylin and eosin, periodic acid Schiff’s reagent, and Masson’s trichrome strain for assessment of renal pathology.
Estimating Kidney Volume
Kidney volume was estimated by means of the Cavalieri principle.19,20 Briefly, whole kidneys embedded in glycolmethacrylate were exhaustively sectioned at 20 µm, and every 10th and 11th section was collected and stained with periodic acid Schiff’s reagent. The "10th" section of each pair was then placed on a microfiche reader (magnification x24.25), and a stereologic test grid (2x2cm) was placed on the microfiche screen. Kidney volume (Vkid) was estimated using the formula: 
|
|
where 
P is the total number of points counted, a(p) is the area associated with each grid point, T is section thickness, and 1/f is the inverse of the section sampling fraction.
Estimating Nephron Number
The above section pairs were used to estimate nephron number, using the physical disector/fractionator combination.20–22 Briefly, the section pairs were projected side by side, with two microscopes modified for projection. One microscope was fitted with a motorized stage and the other was fitted with a rotatable stage to enable section alignment. A grid was placed over each field of view, and points falling on kidney tissue (Pkid), glomeruli (Pglom), and renal corpuscles (Pcorp) were counted. Glomeruli sampled by an unbiased counting frame in the field of view of the 10th section that were not present in the 11th section were counted. Those sampled in the 11th section that were not present in the 10th section were counted to double the efficiency of the technique. This process was repeated for each complete pair of sections. Total nephron number (Nglom,kid) was then estimated using the following equation:
|
|
where 10 was the reciprocal of the section sampling fraction, Ps the number of points overlying all kidney sections, Pf the number of points overlying complete kidney sections, 1/2fa the fraction of the total section area used to count glomeruli, and Q- the actual number of glomeruli counted.
Glomerular Volume
Mean glomerular volume (Vglom) was estimated by using the following formula:
|
|
where Vglom/Vkid is equivalent to Pglom/Pkid.
The total volume of all glomeruli (Vglom (total)) in the kidney was estimated by using the following formula:
|
|
These formulas were then adjusted for estimation of mean renal corpuscle volume (Vcorp) and total volume of all renal corpuscles in the kidney (Vcorp (total)).
Statistics
Differences between heterozygous and wild-type mice were tested with an unpaired Student t test. Values are presented as mean±SEM except for stereological data, which are presented as mean±SD.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
At 14 months of age, there were no significant differences in GFR, renal blood flow, renal vascular resistance, filtration fraction, fractional sodium and potassium excretions, or urinary protein concentration between GDNF heterozygous and wild-type mice (Table 1). In contrast, anesthetized mean arterial pressures were 18 mm Hg higher in GDNF heterozygotes than their wild-type littermates (P<0.001; Table 1). There were no differences in body or kidney weights between the two groups (Table 1).
|
Stereology
Consistent with kidney weights, stereologic estimates of kidney volume were not significantly different between GDNF heterozygous mice and wild-type littermates (Table 2). Total nephron number estimates confirmed the results obtained at 30 days of age, with aged male GDNF heterozygous mice also containing 30% fewer nephrons than their wild-type littermates (P<0.01). At 14 months, however, the glomeruli of GDNF heterozygous kidneys were 20% larger (P<0.01) and mean renal corpuscle volume 30% larger than wild-type kidneys (P<0.01;Table 2). Total glomerular and renal corpuscle volumes (product of glomerular number and glomerular/corpuscle volume) were not different between wild-type and GDNF heterozygous kidneys.
|
Renal Histology and Pathology
Kidneys of 14-month-old GDNF heterozygous and wild-type mice both showed evidence of tubulointerstitial pathology. Most wild-type kidneys analyzed showed areas of focal tubular vacuolation (Figure) and mild inflammation around the renal pelvis. GDNF heterozygous kidneys also showed tubular vacuolation; however, the extent of vacuolation was much greater and more widespread than in wild types (Figure). There was no evidence of degeneration within the vacuolated cells as they displayed viable nuclei and no signs of necrosis or apoptosis. Despite significant hypertrophy, the glomeruli of GDNF heterozygous kidneys showed no evidence of sclerosis or hypercellularity (Figure). In addition, of the GDNF heterozygous kidneys analyzed, one showed areas of focal interstitial inflammation and one contained a cortical cyst.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
A low renal nephron number ("reduced nephron endowment") has been linked with the development of hypertension, glomerulosclerosis, renal failure, and the long-term failure of renal allografts. There are, however, few available animal models with a congenital nephron deficit uncomplicated by changes in birth and adult body weight with which to examine this link. In 1996, three independent research groups generated mice with a homozygous null mutation for GDNF.10,12,13 The homozygous null mutants died within the first 24 hours of postnatal life as the result of bilateral renal agenesis. The heterozygotes, however, were indistinguishable from wild-type littermates in terms of body weight but had reduced renal mass. Recently, our group published a detailed stereological analysis of glomerular number and volumes in these GDNF heterozygous mice, studying the mice at 30 days of age when kidney development is complete.17 We found that glomerular number was 30% lower than wild-type littermates, although glomerular volumes were similar at this age.17
The GDNF heterozygous mouse thus provides a unique animal model with which to examine whether reduced glomerular endowment at birth is a predictor of subsequent development of cardiovascular disease such as essential hypertension later in life. GDNF heterozygous and wild-type mice start to die of natural causes at around 16 months and therefore we chose to study them at 14 months, making the assumption that this was equivalent to late middle age in humans, when the incidence of cardiovascular diseases such as essential hypertension rises markedly in the population.
It has been hypothesized that reductions in glomerular number leads to hypertrophy of the remaining glomeruli with time. This has been well documented in the commonly used 5/6 nephrectomy model. The present study appears to indicate that such hypertrophy also occurs when glomerular numbers are reduced genetically. We previously reported that young GDNF heterozygous mice (30 days old) showed reduced glomerular numbers with no change in mean glomerular volume and thus demonstrated, overall, a reduced total glomerular volume (product of glomerular number and volume). In the current study, we found that by 14 months of age, glomeruli of GDNF heterozygotes were significantly hypertrophied such that the total glomerular volume was no longer different between wild-type and heterozygous littermates. Whole-kidney GFR, renal blood flow, and fractional excretions were also not different between wild-type and GDNF heterozygous littermates. Although micropuncture analysis was not performed in this study, an index of average single nephron function can be calculated by dividing whole-kidney GFR by the number of glomeruli. With 30% fewer nephrons and similar GFR, GDNF heterozygous mice appear to have marked hyperfiltration with 30% greater calculated single nephron GFR values compared with wild-type mice (17.7±1.3 and 13.5±1.2, respectively; P<0.05). Such glomerular hypertrophy and hyperfiltration is often a predictor of glomerular damage and progression to glomerular sclerosis.23 However, GDNF heterozygous mice showed no evidence of glomerular sclerosis or increased proteinuria at 14 months of age. GDNF heterozygous mice did demonstrate greater proximal tubule vacuolation at 14 months of age compared with wild-type mice. The significance of these changes on tubular reabsorption in the GDNF mice are as yet unclear; however, the fractional excretion of sodium and potassium were not different between wild-type and GDNF heterozygous littermates.
Finally, we found that these old GDNF heterozygous mice had mean arterial pressures that were 18 mm Hg higher than their wild-type littermates. At this time, we are not able to say when arterial pressure became elevated. Gerlai et al,24 however, reported that the mean arterial pressure of 4- to 7-month-old GDNF heterozygous and wild-type mice were not significantly different, suggesting the elevation in pressure observed in the present study occurs subsequent to this. Interestingly, this group also showed plasma creatinine levels of the GDNF heterozygous mice to be 10 times higher than wild-type mice, suggesting that GFR tended to be decreased in younger normotensive GDNF heterozygous mice. These findings are compatible with Brenner’s hypothesis2 that a reduced filtration surface area leads to the development of glomerular hypertrophy and hypertension in order to maintain adequate renal function. These findings suggest that the GDNF heterozygous mice may prove to be a useful model of essential hypertension. While anesthesia with Inactin and ketamine has been found to have only mild effects on arterial pressure,25 conscious, sequential blood pressure recordings and renal functions at different ages during the lifespan of the GDNF mice are required to document the time course and accurately determine the degree of the elevation in arterial pressure and changes in glomerular structure and renal function.
A number of experimental models of reduced nephron number have been previously used to study the association between nephron number and blood pressure, each with significant limitations. Rats born to pregnant dams fed a low protein diet do show reduced nephron number; however, they have other major phenotype differences from control mice such as reduced body weight, which confounds simple interpretation of the results.26–28 With 5/6 nephrectomy, the extent of nephron reduction is much more severe than would be expected in the natural genetic variation in humans. Mice overexpressing human insulin-like growth factor also have reduced nephron endowment with glomerular numbers 20% lower than control mice,29 but at this time there have been no reports on renal function or blood pressure of these mice.
GDNF mice have the advantage that their body weights are similar to their wild-type control mice from birth; indeed the control mice have the added advantage of being littermates, and the gene manipulated has a specific role in nephrogenesis itself. GDNF has been shown to be a potent survival factor for a variety of neuronal populations in vitro and in vivo, and some of these populations are reduced in the GDNF null mutant mice.12,13 However, apart from a reduction in the number of Aß-caliber sensory nerve endings in the adult but not neonatal whisker follicle30 and an impairment in learning the position of a hidden platform in a water maze task,24 the GDNF heterozygous mouse appears to have normal-functioning dopaminergic, noradrenergic, and motor systems.12,13,24 Recently, Shen et al31 reported hypoganglionosis of the gastrointestinal tract of GDNF heterozygous mice with up to 1 in 5 GDNF heterozygous mice dying before weaning because of complications resulting from enteric aganglionosis. It is important to note that GDNF heterozygous mice with hypoganglionosis were asymptomatic and thus, given the similar body weights and fecal pellets of GDNF heterozygous and wild-type littermates in the current study, it appears unlikely that enteric hypoganglionosis contributed to the higher blood pressure seen in these 14-month-old GDNF heterozygous mice. Of course, one cannot exclude the possibility that undetected phenotypes might also affect the cardiovascular outcomes in these mice.
Interestingly, an acquired nephron deficit after surgical reduction of renal mass does not always lead to hypertension, even when the reduction is greater than the 30% congenital loss demonstrated in GDNF heterozygous mice. A 50% reduction in glomerular number after unilateral nephrectomy in rats does not lead to the development of hypertension unless the nephrectomy is performed just after birth.32,33 In humans, adult unilateral nephrectomy does not lead to increased prevalence of hypertension in kidney donors unless these donors have underlying conditions such as obesity or diabetes.34,35 However, there does appear to be an increased risk of hypertension for patients who had a kidney removed as children because of Wilms tumor.36,37 Even more dramatic losses in renal mass such as those seen with surgical five-sixths nephrectomy does not always lead to hypertension in rats unless generated by unilateral nephrectomy plus infarction of two thirds of the other kidney.38 Of course, with these surgical models of renal and glomerular deficit, there is an acute and quite dramatic physiological reaction to the loss of renal mass involving the renal sympathetic nervous system and various hormonal systems leading to immediate (minutes) doubling of sodium and potassium excretion and followed by (hours-days) marked elevations in GFR, renal blood flow, and cardiac output, falls in renal vascular resistance, and compensatory growth of the remaining renal tissue in the following days to weeks.38–43 Such dramatic changes cannot be compared with the situation of inherent nephron deficit in which, one could argue, there is no acute physiological reaction but rather a slow adaptive response to the growing needs of the animal.
In summary, mice heterozygous for the GDNF gene that have 30% fewer nephrons than wild types show elevated arterial pressure, normal GFR, and thus hyperfiltration in old age. Unlike the situation at 1 month, glomeruli of 14-month-old GDNF heterozygous mice are hypertrophied; however, this occurs without evidence of glomerular pathology. Thus, the results found in this low nephron-number mouse, uncomplicated by changes in body weight, are in accord with the hypothesis of Brenner et al2 that a reduction in nephron number from birth leads to the development of hypertension and hyperfiltration.
Perspectives
Several animal models exist to examine the link between acquired reductions in nephron number and the subsequent development of cardiovascular and renal diseases; however, there are few animal models of congenital nephron deficit. Our current results suggest that the GDNF heterozygous mouse, with an inherent 30% reduction in nephron number, may provide a useful animal model to study the role of nephron endowment in the pathogenesis of essential hypertension.
|
Acknowledgments |
|---|
This work was supported by the Australian Research Council. Luise Cullen-McEwen was funded by a Biomedical Research Scholarship from the Australian Kidney Foundation. Michelle Kett was funded by a National Health and Medical Research Council Project Grant (124404). The authors would like to acknowledge the assistance of Katrina Worthy.
|
Footnotes |
|---|
Drs Cullen-McEwen and Kett contributed equally to this work.
Received October 3, 2002; first decision October 21, 2002; accepted November 26, 2002.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Mackenzie HS, Lawler EV, Brenner BM. Congenital oligonephropathy: the fetal flaw in essential hypertension? Kidney Int Suppl. 1996; 55: S30–S34.[Medline] [Order article via Infotrieve]
2. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure: less of one, more the other? Am J Hypertens. 1988; 1: 335–347.[Medline] [Order article via Infotrieve]
3. Brenner BM, Milford EL. Nephron underdosing: a programmed cause of chronic renal allograft failure. Am J Kidney Dis. 1993; 21: 66–72.[Medline] [Order article via Infotrieve]
4. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis. 1994; 23: 171–175.[Medline] [Order article via Infotrieve]
5. Sainio K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M, Arumae U, Meng X, Lindahl M, Pachnis V, Sariola H. Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development. 1997; 124: 4077–4087.[Abstract]
6. Pepicelli CV, Kispert A, Rowitch DH, McMahon AP. GDNF induces branching and increased cell proliferation in the ureter of the mouse. Dev Biol. 1997; 192: 193–198.[CrossRef][Medline] [Order article via Infotrieve]
7. Towers PR, Woolf AS, Hardman P. Glial cell line-derived neurotrophic factor stimulates ureteric bud outgrowth and enhances survival of ureteric bud cells in vitro. Exp Nephrol. 1998; 6: 337–351.[CrossRef][Medline] [Order article via Infotrieve]
8. Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 1996; 382: 80–83.[CrossRef][Medline] [Order article via Infotrieve]
9. Vega QC, Worby CA, Lechner MS, Dixon JE, Dressler GR. Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. Proc Natl Acad Sci U S A. 1996 93; 10657–10661.[Medline] [Order article via Infotrieve]
10. Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature. 1996; 382: 73–76.[CrossRef][Medline] [Order article via Infotrieve]
11. Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. GDNF is required for kidney development and enteric innervation. Cold Spring Harb Symp Quant Biol. 1996; 61: 445–457.
12. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature. 1996; 382: 76–79.[CrossRef][Medline] [Order article via Infotrieve]
13. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature. 1996; 382: 70–73.[CrossRef][Medline] [Order article via Infotrieve]
14. Schuchardt A, D’Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 1994; 367: 380–383.[CrossRef][Medline] [Order article via Infotrieve]
15. Enomoto H, Araki T, Jackman A, Heuckeroth RO, Snider WD, Johnson EM Jr, Milbrandt J. GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron. 1998; 21: 317–324.[CrossRef][Medline] [Order article via Infotrieve]
16. Cacalano G, Farinas I, Wang LC, Hagler K, Forgie A, Moore M, Armanini M, Phillips H, Ryan AM, Reichardt LF, Hynes M, Davies A, Rosenthal A. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron. 1998; 21: 53–62.[CrossRef][Medline] [Order article via Infotrieve]
17. Cullen-McEwen LA, Drago J, Bertram JF. Nephron endowment in glial cell line-derived neurotrophic factor (GDNF) heterozygous mice. Kidney Int. 2001; 60: 31–36.[CrossRef][Medline] [Order article via Infotrieve]
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248–254.[CrossRef][Medline] [Order article via Infotrieve]
19. Pakkenberg B, Gundersen HJ. Total number of neurons and glial cells in human brain nuclei estimated by the dissector and the fractionator. J Microsc. 1988; 150: 1–20.[Medline] [Order article via Infotrieve]
20. Kett MM, Alcorn D, Bertram JF, Anderson WP. Glomerular dimensions in spontaneously hypertensive rats: effects of AT1 antagonism. J Hypertens. 1996; 14: 107–113.[Medline] [Order article via Infotrieve]
21. Bertram JF. Analyzing renal glomeruli with the new stereology. Int Rev Cytol. 1995; 161: 111–172.[Medline] [Order article via Infotrieve]
22. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec. 1992; 232: 194–201.[CrossRef][Medline] [Order article via Infotrieve]
23. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol. 2001; 12: 1315–1325.
24. Gerlai R, McNamara A, Choi-Lundberg DL, Armanini M, Ross J, Powell-Braxton L, Phillips HS. Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur J Neurosci. 2001; 14: 1153–1163.[CrossRef][Medline] [Order article via Infotrieve]
25. Lorenz JN. A practical guide to evaluating cardiovascular, renal, and pulmonary function in mice. Am J Physiol. 2002; 282: R1565–R1582.
26. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res. 2001; 49: 460–467.[Medline] [Order article via Infotrieve]
27. Moore VM, Cockington RA, Ryan P, Robinson JS. The relationship between birth weight and blood pressure amplifies from childhood to adulthood. J Hypertens. 1999; 17: 883–888.[CrossRef][Medline] [Order article via Infotrieve]
28. Zimanyi MA, Bertram JF, Black MJ. Nephron number in offspring of rats fed a low protein diet during pregnancy. Image Anal Stereol. 2000; 19: 219–222.
29. Doublier S, Amri K, Seurin D, Moreau E, Merlet-Benichou C, Striker GE, Gilbert T. Overexpression of human insulin-like growth factor binding protein-1 in the mouse leads to nephron deficit. Pediatr Res. 2001; 49: 660–666.[Medline] [Order article via Infotrieve]
30. Fundin BT, Mikaels A, Westphal H, Ernfors P. A rapid and dynamic regulation of GDNF-family ligands and receptors correlate with the developmental dependency of cutaneous sensory innervation. Development. 1999; 126: 2597–2610.[Abstract]
31. Shen L, Pichel JG, Mayeli T, Sariola H, Lu B, Westphal H. GDNF haploinsufficiency causes Hirschsprung-like intestinal obstruction and early-onset lethality in mice. Am J Hum Genet. 2002; 70: 435–447.[CrossRef][Medline] [Order article via Infotrieve]
32. Woods LL, Weeks DA, Rasch R. Hypertension after neonatal uninephrectomy in rats precedes glomerular damage. Hypertension. 2001; 38: 337–342.
33. Woods LL. Neonatal uninephrectomy causes hypertension in adult rats. Am J Physiol. 1999; 276: R974–R978.[Medline] [Order article via Infotrieve]
34. Praga M, Hernandez E, Herrero JC, Morales E, Revilla Y, Diaz-Gonzalez R, Rodicio JL. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000; 58: 2111–2118.[CrossRef][Medline] [Order article via Infotrieve]
35. Toronyi E, Alfoldy F, Jaray J, Remport A, Hidvegi M, Dabasi G, Telkes G, Offenbacher E, Perner F. Evaluation of the state of health of living related kidney transplantation donors. Transpl Int. 1998; 11 (suppl 1): S57–S59.[Medline] [Order article via Infotrieve]
36. Barrera M, Roy LP, Stevens M. Long-term follow-up after unilateral nephrectomy and radiotherapy for Wilms’ tumour. Pediatr Nephrol. 1989; 3: 430–432.[Medline] [Order article via Infotrieve]
37. Makipernaa A, Koskimies O, Jaaskelainen J, Teppo AM, Siimes MA. Renal growth and function 11–28 years after treatment of Wilms’ tumour. Eur J Pediatr. 1991; 150: 444–447.[CrossRef][Medline] [Order article via Infotrieve]
38. Griffin KA, Picken M, Bidani AK. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol. 1994; 4: 2023–2031.[Abstract]
39. Valentin JP. Plasma concentration of atrial natriuretic peptide after acute reduction in functioning renal mass in the rat. Can J Physiol Pharmacol. 1997; 75: 153–157.[Medline] [Order article via Infotrieve]
40. Lopez-Novoa JM, Ramos B, Martin-Oar JE, Hernando L. Functional compensatory changes after unilateral nephrectomy in rats: general and intrarenal hemodynamic alterations. Ren Physiol. 1982; 5: 76–84.[Medline] [Order article via Infotrieve]
41. Shirley DG, Walter SJ. Acute and chronic changes in renal function following unilateral nephrectomy. Kidney Int. 1991; 40: 62–68.[Medline] [Order article via Infotrieve]
42. Valentin JP, Ribstein J, Mimran A. Influence of dopamine and angiotensin II blockade on the acute response to unilateral nephrectomy in rats. J Cardiovasc Pharmacol. 1994; 23: 246–251.[Medline] [Order article via Infotrieve]
43. Furukawa K, Ninomiya I, Shimizu J, Wada T, Matsuura Y. Renal sympathetic nerve activity and the weight of the remaining kidney in unilateral nephrectomized rats. J Auton Nerv Syst. 1997; 63: 91–100.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  J. Zhang, G. A. Massmann, J. C. Rose, and J. P. Figueroa Differential Effects of Clinical Doses of Antenatal Betamethasone on Nephron Endowment and Glomerular Filtration Rate in Adult Sheep Reproductive Sciences, February 1, 2010; 17(2): 186 - 195. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Wu, S. Kitamura, D. M. Truong, T. Rieg, V. Vallon, H. Sakurai, K. T. Bush, D. R. Vera, R. S. Ross, and S. K. Nigam {beta}1-Integrin is required for kidney collecting duct morphogenesis and maintenance of renal function Am J Physiol Renal Physiol, July 1, 2009; 297(1): F210 - F217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Fogelgren, S. Yang, I. C. Sharp, O. J. Huckstep, W. Ma, S. J. Somponpun, E. C. Carlson, C. F. T. Uyehara, and S. Lozanoff Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1166 - F1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shweta, L. A. Cullen-McEwen, M. M. Kett, R. G. Evans, K. M. Denton, S. M. Fitzgerald, W. P. Anderson, and J. F. Bertram Glomerular surface area is normalized in mice born with a nephron deficit: no role for AT1 receptors Am J Physiol Renal Physiol, March 1, 2009; 296(3): F583 - F589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ishibe, A. Karihaloo, H. Ma, J. Zhang, A. Marlier, M. Mitobe, A. Togawa, R. Schmitt, J. Czyczk, M. Kashgarian, et al. Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology Development, January 15, 2009; 136(2): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Iliescu, R. Cazan, G. R. McLemore Jr., M. Venegas-Pont, and M. J. Ryan Renal blood flow and dynamic autoregulation in conscious mice Am J Physiol Renal Physiol, September 1, 2008; 295(3): F734 - F740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, H. van Goor, R. Havinga, J. F. W. Baller, V. W. Bloks, F. R. van der Leij, P. J. J. Sauer, F. Kuipers, G. Navis, and M. H. de Borst Neonatal dexamethasone administration causes progressive renal damage due to induction of an early inflammatory response Am J Physiol Renal Physiol, April 1, 2008; 294(4): F768 - F776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shi, D. Patschan, G. P. H. Dietz, M. Bahr, M. Plotkin, and M. S. Goligorsky Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury Am J Physiol Renal Physiol, January 1, 2008; 294(1): F229 - F235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Quinlan, F. Kaplan, N. Sweezey, and P. Goodyer LGL1, a novel branching morphogen in developing kidney, is induced by retinoic acid Am J Physiol Renal Physiol, October 1, 2007; 293(4): F987 - F993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dickinson, K. Moritz, E. M. Wintour, D. W. Walker, and M. M. Kett A comparative study of renal function in the desert-adapted spiny mouse and the laboratory-adapted C57BL/6 mouse: response to dietary salt load Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1093 - F1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Quinlan, M. Lemire, T. Hudson, H. Qu, A. Benjamin, A. Roy, E. Pascuet, M. Goodyer, C. Raju, Z. Zhang, et al. A Common Variant of the PAX2 Gene Is Associated with Reduced Newborn Kidney Size J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1915 - 1921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Singh, L. A. Cullen-McEwen, M. M. Kett, W.-M. Boon, J. Dowling, J. F. Bertram, and K. M. Moritz Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring J. Physiol., March 1, 2007; 579(2): 503 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dziarmaga, P.-A. Hueber, D. Iglesias, N. Hache, A. Jeffs, N. Gendron, A. MacKenzie, M. Eccles, and P. Goodyer Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2 Am J Physiol Renal Physiol, October 1, 2006; 291(4): F913 - F920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Tsui, S. J. Shankland, and B. A. Pierchala Glial Cell Line-Derived Neurotrophic Factor and Its Receptor Ret Is a Novel Ligand-Receptor Complex Critical for Survival Response during Podocyte Injury J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1543 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dziarmaga, M. Eccles, and P. Goodyer Suppression of Ureteric Bud Apoptosis Rescues Nephron Endowment and Adult Renal Function in Pax2 Mutant Mice J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1568 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C M Taylor and H Narchi Risk of hypertension in children with multicystic dysplastic kidney. Arch. Dis. Child., March 1, 2006; 91(3): 277 - 278. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zandi-Nejad, V. A. Luyckx, and B. M. Brenner Adult Hypertension and Kidney Disease: The Role of Fetal Programming Hypertension, March 1, 2006; 47(3): 502 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Hoy, M. D. Hughson, J. F. Bertram, R. Douglas-Denton, and K. Amann Nephron Number, Hypertension, Renal Disease, and Renal Failure J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2557 - 2564. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Suzuki, T. Tokuriki, K. Saito, A. Hishida, and K. Suzuki Glomerular hyperfiltration and hypertrophy in the rat hypoplastic kidney as a model of oligomeganephronic disease Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1362 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. M. Welham, P. R. Riley, A. Wade, M. Hubank, and A. S. Woolf Maternal diet programs embryonic kidney gene expression Physiol Genomics, June 16, 2005; 22(1): 48 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Shah, R. V. Sampogna, H. Sakurai, K. T. Bush, and S. K. Nigam Branching morphogenesis and kidney disease Development, April 1, 2004; 131(7): 1449 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Qi, I. Whitt, A. Mehta, J. Jin, M. Zhao, R. C. Harris, A. B. Fogo, and M. D. Breyer Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance Am J Physiol Renal Physiol, March 1, 2004; 286(3): F590 - F596. [Abstract] [Full Text]
|
|
|
|
 |
|
 O. Grisk and R. Rettig Interactions between the sympathetic nervous system and the kidneys in arterial hypertension Cardiovasc Res, February 1, 2004; 61(2): 238 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Rostand Oligonephronia, primary hypertension and renal disease: 'is the child father to the man?' Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1434 - 1438. [Full Text] [PDF]
|
|
|
|
|
|
S. G. Rostand Oligonephronia, primary hypertension and renal disease: 'is the child father to the man?' Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1434 - 1438. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||